In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

Analyst Divya Gangahar from Morgan Stanley maintained a Buy rating on Grab (GRAB – Research Report) and increased the price target to ...

Toll Brothers (TOL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

As usual, Nvidia stock is climbing in 2024, earning 136.3% year-to-date gains for shareholders, although shares have lost ...

Here are seven undervalued stocks to buy, according to CFRA, with forward earnings multiples of less than 15: *As of Sept. 25 ...

FTAI Aviation (FTAI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

These stocks are trading at attractive valuations relative to their history, especially in light of their opportunities in ...

Nvidia Corporation's stock faces volatility despite earnings growth. We examine support levels to watch and telltale signs to ...

This is not a “set it and forget it” scheme. You want these stocks on your watchlist so that when you find a buy rating or a good time to make your move, you can invest appropriately.

Read here for an update on Tesla's upcoming catalysts in Oct., including the robotaxi event and Q3 release, and TSLA's ...

Shares of chipmaker Advanced Micro Devices (AMD) are trading lower at the time of writing, even though Citi Research kept its Buy rating on AMD after a 15% rise in August notebook shipments.

Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...